| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N02AA01 | G | Morphine sulfate - 30mg | 12320 | 108725/1 | SKENAN LP | 30mg | 14 | Capsule, prolonged release microgranules | Oral | Minapharm Halabi | Ethypharm | France | 972,942 L.L | 23.08 | A2 | Ethypharm | France | 10/11/20 |
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N02AA01 | B | Morphine sulfate - 30mg | 3633 | 38940 | MST CONTINUS | 30mg | 60 | Tablet, film coated, prolonged release | Oral | Mersaco | Bard Pharmaceuticals Ltd | UK | 2,289,908 L.L | 23.08 | B | Napp Pharmaceuticals Ltd | UK | 10/11/20 |

